To date, 2016 was without a doubt the most successful year for the cannabis industry, and it’s only going to continue flourishing.
As such, the Investing News Network (INN) covered a number of the year’s biggest cannabis news stories–ranging from top stocks, legalization in the US and the release of the Task force in Canada.
With an abundance of cannabis news stories, investors were more interested in the sector than ever.
Read on to see what five top cannabis news stories 2016 caught the attention of our investor audience.

1. 19 Canadian Marijuana Stocks

First on the top cannabis news stories 2016 is a look at 19 Canadian marijuana stocks. At the time, the Canadian government’s task force on legalization of marijuana hadn’t been released, but cannabis stocks were still soaring. In the summer of 2016, Predictive Index analyst Jason Zandberg put forth the prediction that the cannabis market would be worth $4.9 billion by 2019, and climbing to $7.4 billion within the first five years of legalization.
Bearing that in mind, it’s no wonder investors were keen to read about cannabis stocks already listed on Canadian exchanges, including Canopy Growth (TSX:CGC), Mettrum (TSXV:MT), OrganiGram (TSXV:OGI), Aurora Cannabis (TSXV:ACB), THC Biomed (CSE:THC), among others.

2. 10 Top Canadian Cannabis Stocks

As it can be seen, Canadian cannabis stocks were a hot read in 2016. While the former focus on a variety of Canadian marijuana stocks, this one looks at the 10 top performing stocks year-to-date (as of October).
With the help from a list compiled by CanTech Letter, INN dove in with some additional information about the companies listed–some of which were mentioned above–including, Maple Leaf Green World (TSXV:MGW), Emerald Health Therapeutics (TSXV:EMH), and Cannabix Technologies (CSNX:BLO).

3. How to Find the Best Cannabis Stocks to Invest in

Keeping with the cannabis stocks theme, our audience was keen to learn how to find the best cannabis stocks to invest in. Like the previous two articles, this one had been done before legalization in Canada and the US (at a federal level) was in play. In the article, former Wall Street attorney Chris Milenkevich talks with INN about what investors should look for when stepping into the cannabis stocks sector.

4. Cannabis Outlook 2017: Legalization on the Horizon

Taking the above three articles into consideration, it should come as no surprise that looking ahead, investors were eager to look at what’s in store in the coming year. With legalization in Canada ready to launch in the spring, INN had the chance to speak with 420 Investor Alan Brochstein to talk about how the cannabis industry is shaping up this year.

5. Why Aurora’s Expansion is Significant to the Cannabis Industry

Rounding out the list of top cannabis news stories 2016 is an interview INN did later in the year with vice president of Aurora Cannabis, Cam Battley. In November, the company announced that it had begun construction on an 80,000 square foot expansion, called “Aurora Sky.” When completed, it is projected to  be the largest cannabis production facility in the world.
In the interview, Battley discusses how the facility will set Aurora apart from other cannabis companies, why they chose Dutch design for the expansion, and how the legalization of recreational marijuana will impact the facility.
Don’t forget to follow us @INN_Resource for real-time news updates.
Securities Disclosure: I, Jocelyn Aspa, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: Mettrum Health is a client of the Investing News Network. This article is not paid for content.

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less

As Canadian operators race to strengthen their positions in the cannabis landscape, are international pursuits outside North America still top of mind?

The role that mergers and acquisitions (M&A) have played in the expansion of Canadian companies across the globe has been monumental for the growth of the cannabis industry. Now the space has reached a critical point as the demands of the US market increase.

Keep reading... Show less

It’s been just over a year since recreational cannabis was legalised in the Australian Capital Territory (ACT), home to the nation’s capital city of Canberra.

Announced on September 25, 2019, and brought into effect on January 31, 2020, the rules make it legal to possess and personally use small amounts of cannabis.

Keep reading... Show less

Pac Roots Cannabis Corp. (CSE: PACR) (“PacRoots” or the “Company”), announces the closing of its previously announced non-brokered private placement (see press release dated January 25, 2021).

Aggregate gross proceeds of $1,340,685.90 were raised through the issuance of 7,448,255 units (each a “Unit”). Each Unit consists of one common shares and one share purchase warrant. Each warrant is exercisable at a price of $0.30 per share until February 23, 2024.

Keep reading... Show less

 Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States will release its fourth quarter 2020 financial results on Tuesday, March 23, 2021 before markets open. Following the earnings release, management will host a conference call at 8:30 AM Eastern Time to review the financial results.

All interested parties can join the conference call by dialing 1-888-231-8191 or 1-647-427-7450, conference ID: 7066881. Please dial in 15 minutes prior to the call to secure a line. The conference call will be archived for replay until March 30, 2021 . To access the archived conference call, please dial 1-855-859-2056 and enter the encore code 7066881.

Keep reading... Show less